MEASUREMENT OF PROBLEM BEHAVIOUR DURING MEDICATION EVALUATIONS
Saved in:
ZARCONE, J., ET AL., MEASUREMENT OF PROBLEM BEHAVIOUR DURING MEDICATION EVALUATIONS. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, Vol. 52, no. 12 (2008), p. 1015-1028.
Ref.
155397
Location:
SIIS R.104 Archivo
Palabras clave:
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Metodología, Trastornos de la conducta, Tratamiento médico
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Metodología, Trastornos de la conducta, Tratamiento médico
Similar Items: MEASUREMENT OF PROBLEM BEHAVIOUR DURING MEDICATION EVALUATIONS
- THE EFFECTIVENESS OF MOOD STABILIZERS AND ANTIEPILEPTIC MEDICATION FOR THE MANAGEMENT OF BEHAVIOUR PROBLEMS IN ADULTS WITH INTELLECTUAL DISABILITY: A SYSTEMATIC REVIEW
- EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR OF PERSONS WITH DEVELOPMENTAL DISABILITIES: I. A DOUBLE-BLIND CROSSOVER STUDY USING MULTIPLE MEASURES
- VIOLENT INCIDENTS AND THE USE OF ANTIPSYCHOTIC MEDICATION WITHIN A SPECIALIST CHALLENGING BEHAVIOUR UNIT: AN EVALUATION OF THE POOLE APPROACH TO CHALLENGING BEHAVIOUR
- USING MEDICATION TO MANAGE BEHAVIOUR PROBLEMS AMONG ADULTS WITH A LEARNING DISABILITY. QUICK REFERENCE GUIDE (QRG)
- PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
- THE TREATMENT OF CHALLNEGING BEHAVIOUR IN INTELLECTUAL DISABILITIES: COST EFFECTIVENESS ANALYSIS